Authors
Loading...
Novel compounds exhibit antibacterial activity against Pseudomonas and Staphylococcus aureus, highlighting potential for drug development.
Ali et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: